Definition of “Tissue-Based Biomarker,” its Place in Medicine, and Molecular Pathology


Sağol Ö., Sarıoğlu S.

Biomarkers in Carcinoma of Unknown Primary, Sülen Sarıoğlu,Özgül Sağol,Anıl Aysal, Editör, Springer, London/Berlin , Zug, ss.1-19, 2022

  • Yayın Türü: Kitapta Bölüm / Mesleki Kitap
  • Basım Tarihi: 2022
  • Yayınevi: Springer, London/Berlin 
  • Basıldığı Şehir: Zug
  • Sayfa Sayıları: ss.1-19
  • Editörler: Sülen Sarıoğlu,Özgül Sağol,Anıl Aysal, Editör
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

A biomarker is a feature that is shown to indicate a physiologic or pathologic condition. The roles of biomarkers in histopathological evaluation are expanding, and pathologists must work with these tools like a conductor of an orchestra. Diagnostic, prognostic, and predictive biomarkers support patient diagnosis and treatment in multiple ways. Some biomarkers are patient-related, and some are drug-related. A single biomarker is sometimes important for all these purposes. Finding biomarkers is a multistep process and requires integrated study of different disciplines. Standards for quality, sensitivity, and specificity of biomarkers are described internationally, and a biomarker should meet all these criteria being used in patient care. Immunohistochemistry, in situ hybridization, polymerase chain reaction, sequencing, and bioinformatic facilities are required for proper diagnosis in a pathology laboratory.